Clinical and economic burden of antimicrobial resistance.
about
Antimicrobial stewardship in paediatricsAssociation between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patientsAntibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance.Long-term effect of computer-assisted decision support for antibiotic treatment in critically ill patients: a prospective ‘before/after’ cohort studyThe changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation.The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.Impact of an educational hands-on project on the antimicrobial, antitumor and anti-inflammatory properties of plants on Portuguese students' awareness, knowledge, and competences.Portuguese students' knowledge of antibiotics: a cross-sectional study of secondary school and university students in Braga.Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.Antimicrobial Stewardship Initiatives Throughout Europe: Proven Value for MoneyThe Use of Bloodstream Infection Mortality to Measure the Impact of Antimicrobial Stewardship Interventions: Assessing the EvidenceInhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009Microbicidal effects of α- and θ-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa.Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008Factors associated with variation in estimates of the cost of resistant infectionsAn institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsisClinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii.Overcoming drug resistance with alginate oligosaccharides able to potentiate the action of selected antibiotics.Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens.Mechanisms of peptide-induced pore formation in lipid bilayers investigated by oriented 31P solid-state NMR spectroscopy.phiBIOTICS: catalogue of therapeutic enzybiotics, relevant research studies and practical applications.Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort studyVentilator-associated tracheitis in children: does antibiotic duration matter?Public knowledge, attitudes, and experience regarding the use of antibiotics in Italy.Implementation of antimicrobial stewardship policies in U.S. hospitals: findings from a national surveyAn empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections.Pharmacokinetics and safety of intravenous ceftolozane-tazobactam in healthy adult subjects following single and multiple ascending doses.Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011.Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis.Economic value of dispensing home-based preoperative chlorhexidine bathing cloths to prevent surgical site infectionModeling non-inherited antibiotic resistance.Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.A Survey and Analysis of the American Public's Perceptions and Knowledge About Antibiotic Resistance.Bovine salmonellosis in northeast of Iran: frequency, genetic fingerprinting and antimicrobial resistance patterns of Salmonella spp.Public knowledge, attitudes and practices regarding antibiotic use in KosovoThe challenges of antimicrobial drug resistance in Greece.The role of the laboratory in choosing antibiotics.
P2860
Q26740379-81FF7835-4E8F-445E-9079-2445C487085DQ26751621-7357C25E-9234-4507-81FB-A6ED876DF692Q28545750-AAEC8F3E-0432-4DA6-87D5-1E611C7174B0Q30047328-7A8A3B50-E854-4681-9476-F63A582A7A0BQ30375493-80CA260B-4520-44D9-BABA-D1CAEDAF5DC1Q30379659-993E0232-926C-4C18-B42D-9967E763524BQ30388991-269825EB-B220-4630-A63B-91E106DCABBEQ33506185-5CA72D4C-1A27-4ED2-BA8C-B8F7DD13B93DQ33559105-1D697C51-03A6-4108-9955-B9C9EE66B60FQ33564287-0A05E6F4-F016-4E0F-BF8A-A58F84D7A368Q33564316-F6C66FA1-288C-42D1-AD39-3B697010BD4BQ33719201-6E0B09B5-6909-4125-B592-38ADBD27EDE1Q33767148-A89FC544-EBA0-4912-828D-D2A69BDA0A1BQ33774311-5B30C6A4-0A6A-4210-B128-A8108E64A468Q33816251-AAEE6EFB-CFD4-405B-BDA6-216CCD74AA54Q34027016-F9F6A85D-2578-420F-AC0B-8E6FFC655068Q34077002-EB4F2802-2DE6-4A24-8423-98B1703AFD89Q34194422-FA67610F-C32A-4842-A959-77282A79B5CDQ34346016-B519516E-BF4E-4823-BDF0-CD503FA200C2Q34348698-90264E34-632F-418B-8790-6FF9A51D6AC4Q34366895-54F77D06-37D7-49AD-A00E-4F4DB44E8BBAQ34456490-09900D7E-C951-4E3B-81F3-0D599315FF4CQ34622345-3F1250F2-59D0-4C33-94B9-735C9C946D21Q34686057-BF21CB9F-249C-4AD8-92DE-C79D700EB9ECQ34990611-44292E89-DB88-4362-A20C-633F3843AEA8Q35078345-AE070416-A509-4765-AD37-0D6270CF37E9Q35166921-4AD1317A-FAF4-4AF7-9D25-F0C38D6F251CQ35545776-BE96120F-F0CC-4CF5-9D7F-9E945E3FB71CQ35682692-E04836A1-D25D-4D1B-A106-04952938DFFDQ36018548-EB95F541-2DA4-4D0A-9818-11601CCF04FAQ36035185-5050AA01-A41F-4217-B0CD-9A91E22829AAQ36066000-30A498A2-96FB-4285-ADC6-229098BE5AABQ36066041-DB3BDB28-9BC6-43A8-B2B8-33EA6A61AAE8Q36078963-9D1771A0-BD8D-45EC-8BA0-15B149C5E251Q36937446-DCEA7148-B19F-4C3C-8F58-AF788E074401Q37057333-DDFABB5E-689D-4405-ABC6-11D1B0DE45DFQ37285118-27F1D85E-4313-4C91-81DE-EFAF2C1F24E7Q37745718-8964D2B8-10A2-4D4F-AF13-ABE41B318AB4Q37892237-E244BBDA-A7E1-407B-A613-328B3B8A2F0DQ37899213-C3F852A6-B8B0-41D6-8900-F53810031904
P2860
Clinical and economic burden of antimicrobial resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical and economic burden of antimicrobial resistance.
@en
Clinical and economic burden of antimicrobial resistance.
@nl
type
label
Clinical and economic burden of antimicrobial resistance.
@en
Clinical and economic burden of antimicrobial resistance.
@nl
prefLabel
Clinical and economic burden of antimicrobial resistance.
@en
Clinical and economic burden of antimicrobial resistance.
@nl
P2860
P356
P1476
Clinical and economic burden of antimicrobial resistance
@en
P2093
Lisa L Maragakis
Sara E Cosgrove
P2860
P304
P356
10.1586/14787210.6.5.751
P577
2008-10-01T00:00:00Z